Serum soluble vascular cell adhesion molecule-1: Role as a surrogate marker of angiogenesis

Journal of the National Cancer Institute

Volumn 92, Issue 16, 2000, Pages 1329-1336

  Byrne, Ged J ^a   Ghellal, Ashur ^a   Iddon, Julie ^a   Blann, Andrew D ^a   Venizelos, Vasil ^a   Kumar, Shant ^b   Howell, Anthony ^c   Bundred, Nigel J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0034674895     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.16.1329     Document Type: Article

References (42)

1. The implications of angiogenesis for the biology and therapy of cancer metastasis
2. Novel growth regulatory factors and tumour angiogenesis
3. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
4. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
5. Microvessel quantitation and prognosis in invasive breast carcinoma
6. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
7. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis
8. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
9. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium
10. Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells
11. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
12. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
13. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance
14. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1
15. Changes of Willebrand factor level in blood plasma of cancer patients and its role in hemostatic disturbances
16. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
17. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer
18. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
19. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium
20. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
21. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis
22. Assessment of response to therapy in advanced breast cancer: A project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland
23. von Willebrand factor antigen: A radial immunodiffusion method evaluated and compared with an ELISA method
24. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
25. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas
26. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
27. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth
28. Inhibition of angiogenesis by antiestrogens
29. The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer
30. Cellular adhesion molecules in rheumatoid arthritis: Regulation by cytokines and possible clinical importance
31. Expression and functional characterization of a soluble form of endothelial-leukocyte adhesion molecule 1
32. Leukocyte-endothelial adhesion and angiogenesis in tumors
33. Requirement of vascular integrin alpha v beta 3 for angiogenesis
34. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors
35. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1
36. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms
37. Suppression of tumor growth in vivo by local and systemic 90K level increase
38. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes
39. Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone
40. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer
41. The angiogenesis inhibitor AGM-1470 selectively increases E-selectin
42. VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays